Hollow victory for Baxter in Fresenius patent row?
This article was originally published in Clinica
Baxter has prevailed in an ongoing patent dispute with Fresenius Medical Care (FMC), after a US district court in California judged the latter to be guilty of infringement and ordered the company to pay royalties to Baxter on sales of its 2008K haemodialysis machine. In addition, FMC was ordered to stop manufacturing and selling the product in the US from January 1 2009.
You may also be interested in...
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.
A medtech industry group is asking the Trump administration to clarify if small medical device companies that have equity investors qualify for small business loans and forgiveness under the coronavirus relief package.
Amarin had argued that Vascepa’s sales success showed that its patents were not obvious, but the court found otherwise, even as it concluded that Hikma, Dr. Reddy's and West-Ward has infringed on the fish oil pill's patents.